KLOW 80

KLOW 80

KLOW 80 is a proprietary research-grade blend of four widely-studied peptides in a single lyophilised vial. Each vial contains 80mg of total peptide, formulated for laboratory investigation of multi-peptide synergy models in regenerative and tissue-integrity research.

Composition (per vial)

• GHK-Cu (Copper Tripeptide-1) — 50mg
• BPC-157 — 10mg
• TB-500 (Thymosin Beta-4 fragment) — 10mg
• KPV (Lysine-Proline-Valine) — 10mg

Specifications

• Total peptide content: 80mg per vial
• Form: Lyophilised white powder
• Purity: >99% (HPLC tested) per individual peptide component
• Storage: 2–8°C, dark, desiccated. Reconstituted solution stable ≤14 days refrigerated
• Third-party Certificate of Analysis available on request

Research context

The KLOW 80 combination is used in academic research to study potential synergy between four peptides with established individual research histories. GHK-Cu is a naturally-occurring copper-binding tripeptide studied for connective-tissue modelling; BPC-157 is a pentadecapeptide derivative of a gastric juice protein studied in regenerative biology; TB-500 is a synthetic fragment of Thymosin Beta-4 used in tissue-repair research; and KPV is a tripeptide fragment of α-MSH studied in anti-inflammatory research.

These products are supplied strictly for laboratory research purposes only. Not for human consumption, medical use, or veterinary application. Not approved by MHRA. By purchasing, you confirm use in a qualified research environment.